154 related articles for article (PubMed ID: 31392646)
1. Important prognostic factors in leiomyosarcoma survival: a National Cancer Database (NCDB) analysis.
Gootee J; Sioda N; Aurit S; Curtin C; Silberstein P
Clin Transl Oncol; 2020 Jun; 22(6):860-869. PubMed ID: 31392646
[TBL] [Abstract][Full Text] [Related]
2. Leiomyosarcoma of the head and neck: A 17-year single institution experience and review of the National Cancer Data Base.
Workman AD; Farquhar DR; Brody RM; Parasher AK; Carey RM; Purkey MT; Nagda DA; Brooks JS; Hartner LP; Brant JA; Newman JG
Head Neck; 2018 Apr; 40(4):756-762. PubMed ID: 29286183
[TBL] [Abstract][Full Text] [Related]
3. Leiomyosarcoma: Prognostic outline of a rare head and neck malignancy.
Saluja TS; Iyer J; Singh SK
Oral Oncol; 2019 Aug; 95():100-105. PubMed ID: 31345375
[TBL] [Abstract][Full Text] [Related]
4. Impact of adjuvant treatment and prognostic factors in stage I uterine leiomyosarcoma patients treated in Commission on Cancer®-accredited facilities.
Vaz J; Tian C; Richardson MT; Chan JK; Mysona D; Rao UN; Powell MA; Shriver CD; Hamilton CA; Casablanca Y; Maxwell GL; Darcy KM
Gynecol Oncol; 2020 Apr; 157(1):121-130. PubMed ID: 31954536
[TBL] [Abstract][Full Text] [Related]
5. Primary anatomical site, adjuvant therapy, and other prognostic variables for dedifferentiated liposarcoma.
Gootee J; Aurit S; Curtin C; Silberstein P
J Cancer Res Clin Oncol; 2019 Jan; 145(1):181-192. PubMed ID: 30361927
[TBL] [Abstract][Full Text] [Related]
6. Malignant smooth muscle tumours of soft tissue--a demographic and clinicopathological study at a tertiary care hospital.
Shah H; Bhurgri Y; Pervez S
J Pak Med Assoc; 2005 Apr; 55(4):138-43. PubMed ID: 15918623
[TBL] [Abstract][Full Text] [Related]
7. Comparison of clinicopathological features and outcomes in patients with primary leiomyosarcoma of bone and soft tissue.
Gusho CA; Blank AT; Gitelis S
J Surg Oncol; 2021 Apr; 123(5):1274-1283. PubMed ID: 33524203
[TBL] [Abstract][Full Text] [Related]
8. Leiomyosarcoma of the urinary bladder: A SEER database study and comparison to leiomyosarcomas of the uterus and extremities/trunk.
Coiner BL; Cates J; Kamanda S; Giannico GA; Gordetsky JB
Ann Diagn Pathol; 2021 Aug; 53():151743. PubMed ID: 33964611
[TBL] [Abstract][Full Text] [Related]
9. Primary anatomical site as a prognostic factor for pleomorphic liposarcoma.
Lee HG; Aurit S; Silberstein P; Gootee J
J Cancer Res Clin Oncol; 2020 Jun; 146(6):1501-1508. PubMed ID: 32248301
[TBL] [Abstract][Full Text] [Related]
10. Somatic Leiomyosarcoma of the Soft Tissues: A Single-Institutional Analysis of Factors Predictive of Survival in 164 Patients.
Harati K; Daigeler A; Lange K; Niggemann H; Stricker I; Steinau HU; Lehnhardt M; Goertz O
World J Surg; 2017 Jun; 41(6):1534-1541. PubMed ID: 28116485
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors in soft tissue leiomyosarcoma of the extremities: a retrospective analysis of 42 cases.
Massi D; Beltrami G; Mela MM; Pertici M; Capanna R; Franchi A
Eur J Surg Oncol; 2004 Jun; 30(5):565-72. PubMed ID: 15135488
[TBL] [Abstract][Full Text] [Related]
12. Leiomyosarcoma: investigation of prognostic factors for risk-stratification model.
Kim HJ; Cho YJ; Kim SH; Rha SY; Ahn JB; Yang WI; Lee YH; Suh JS; Roh JK; Kim KS; Choi YD; Shin KH; Kim HS
Int J Clin Oncol; 2015 Dec; 20(6):1226-32. PubMed ID: 26123311
[TBL] [Abstract][Full Text] [Related]
13. Outcome and prognosis in uterine sarcoma and malignant mixed Mullerian tumor.
Burghaus S; Halmen S; Gass P; Mehlhorn G; Schrauder MG; Lux MP; Renner SP; Beckmann MW; Hein A; Thiel FC
Arch Gynecol Obstet; 2016 Aug; 294(2):343-51. PubMed ID: 26711836
[TBL] [Abstract][Full Text] [Related]
14. Prognosis and treatment of uterine leiomyosarcoma: A National Cancer Database study.
Seagle BL; Sobecki-Rausch J; Strohl AE; Shilpi A; Grace A; Shahabi S
Gynecol Oncol; 2017 Apr; 145(1):61-70. PubMed ID: 28317559
[TBL] [Abstract][Full Text] [Related]
15. A Comparison of Outcomes and Prognostic Features for Radiation-Associated Angiosarcoma of the Breast and Other Radiation-Associated Sarcomas.
Mito JK; Mitra D; Barysauskas CM; Mariño-Enriquez A; Morgan EA; Fletcher CDM; Raut CP; Baldini EH; Doyle LA
Int J Radiat Oncol Biol Phys; 2019 Jun; 104(2):425-435. PubMed ID: 30703514
[TBL] [Abstract][Full Text] [Related]
16. Trends in ovarian conservation and association with survival in premenopausal patients with stage I leiomyosarcoma.
Sia TY; Huang Y; Gockley A; Melamed A; Khoury-Collado F; St Clair C; Hou JY; Tergas AI; Hershman DL; Wright JD
Gynecol Oncol; 2021 Jun; 161(3):734-740. PubMed ID: 33810881
[TBL] [Abstract][Full Text] [Related]
17. The influence of primary site on outcomes in leiomyosarcoma: a review of clinicopathologic differences between uterine and extrauterine disease.
Farid M; Ong WS; Tan MH; Foo LS; Lim YK; Chia WK; Soh LT; Poon D; Lee MJ; Ho ZC; Jeevan R; Chin F; Teo M; Quek R
Am J Clin Oncol; 2013 Aug; 36(4):368-74. PubMed ID: 22772425
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous leiomyosarcoma: dermal and subcutaneous.
Wong GN; Webb A; Gyorki D; McCormack C; Tran P; Ngan SY; Slavin J; Henderson MA
Australas J Dermatol; 2020 Aug; 61(3):243-249. PubMed ID: 32537765
[TBL] [Abstract][Full Text] [Related]
19. Smooth muscle tumors of the gastrointestinal tract: analysis of prognostic factors.
Chou FF; Eng HL; Sheen-Chen SM
Surgery; 1996 Feb; 119(2):171-7. PubMed ID: 8571202
[TBL] [Abstract][Full Text] [Related]
20. Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy.
Giuntoli RL; Metzinger DS; DiMarco CS; Cha SS; Sloan JA; Keeney GL; Gostout BS
Gynecol Oncol; 2003 Jun; 89(3):460-9. PubMed ID: 12798712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
